Gelonghui, September 9丨Aojing Medical (688613.SH) announced that Weifang Aojing Health Technology Co., Ltd., a wholly-owned subsidiary of the company, recently received approval from the Shandong Drug Administration to issue a “Medical Device Production License”, and the new production line commissioned to produce artificial bone repair materials passed the compliance inspection with medical device production quality management standards.

This time, the production line that has passed the medical device production quality management standards compliance inspection has an annual production capacity of 2 million boxes of mineralized collagen artificial bone repair materials. This time, Weifang Aojing Health Technology Co., Ltd. has obtained a “Medical Device Production License”, which can organize the contract production of the company's artificial bone repair material products in accordance with regulations, rules, regulatory documents, mandatory standards and registered product technical requirements, which is conducive to safeguarding the company's product quality and production capacity, and further meeting market demand.